The REACH program aims to accelerate the development of academic institutions’ biomedical discoveries into devices, therapeutics and other tools to improve patient care and outcomes. To achieve this goal, the NIH matches member centers with federal and private sector partners who can offer resources and product development guidance.
The NIH’s biomedical innovation network already includes three REACH hubs and three NIH Centers for Accelerated Innovations. The five new REACH hubs and their lead institutions are:
- Kentucky Network for Innovation & Commercialization — University of Kentucky (Lexington)
- Rutgers Optimizes Innovation program — Rutgers Biomedical and Health Sciences (Newark, N.J.)
- Midwest Biomedical Accelerator Consortium — University of Missouri (Columbia)
- Colorado Anschutz Medical Campus REACH Hub
- Washington Entrepreneurial REACH Hub — University of Washington (Seattle)
More articles on innovation:
Mount Sinai’s 8th annual innovation festival centers on AI
Children’s National names 6 winners of NICU device competition
How Nuvance Health’s innovation drives population health, and the key tech initiatives coming next
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
